WALDENSTROM'S MACROGLOBULINEMIA REFRACTORY

Clinical trials for WALDENSTROM'S MACROGLOBULINEMIA REFRACTORY explained in plain language.

Never miss a new study

Get alerted when new WALDENSTROM'S MACROGLOBULINEMIA REFRACTORY trials appear

Sign up with your email to follow new studies for WALDENSTROM'S MACROGLOBULINEMIA REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo tested for rare blood cancer

Disease control Ongoing

This study is testing a new drug called sonrotoclax, both by itself and combined with another drug called zanubrutinib, for people with Waldenström Macroglobulinemia, a rare blood cancer. It aims to see if these treatments can shrink the cancer and control the disease, while also…

Matched conditions: WALDENSTROM'S MACROGLOBULINEMIA REFRACTORY

Phase: PHASE2 • Sponsor: BeOne Medicines • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

WALDENSTROM'S MACROGLOBULINEMIA REFRACTORY

Get alerted when new WALDENSTROM'S MACROGLOBULINEMIA REFRACTORY trials appear

New drug combo tested for rare blood cancer